Evaluation of the validated intraoperative bleeding scale in liver surgery: study protocol for a multicenter prospective study

BackgroundSurgical hemostasis has become one of the key principles in the advancement of surgery. Hemostatic agents are commonly administered in many surgical specialties, although the lack of consensus on the definition of intraoperative bleeding or of a standardized system for its classification m...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in surgery 2023-10, Vol.10, p.1223225-1223225
Main Authors: Aparicio-López, Daniel, Asencio-Pascual, José Manuel, Blanco-Fernández, Gerardo, Cugat-Andorrá, Esteban, Gómez-Bravo, Miguel Ángel, López-Ben, Santiago, Martín-Pérez, Elena, Sabater, Luis, Ramia, José Manuel, Serradilla-Martín, Mario
Format: Article
Language:English
Subjects:
hemostatic agent
intraoperative bleeding
liver surgery
predictive score
Surgery
surgical hemostasis
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BackgroundSurgical hemostasis has become one of the key principles in the advancement of surgery. Hemostatic agents are commonly administered in many surgical specialties, although the lack of consensus on the definition of intraoperative bleeding or of a standardized system for its classification means that often the most suitable agent is not selected. The recommendations of international organizations highlight the need for a bleeding severity scale, validated in clinical studies, that would allow the selection of the best hemostatic agent in each case. The primary objective of this study is to evaluate the VIBe scale (Validated Intraoperative Bleeding Scale) in humans. Secondary objectives are to evaluate the scale's usefulness in liver surgery; to determine the relationship between the extent of bleeding and the hemostatic agent used; and to assess the relationship between the grade of bleeding and postoperative complications. MethodsProspective multicenter observational study including 259 liver resections that meet the inclusion criteria: patients scheduled for liver surgery at one of 10 medium-high volume Spanish HPB centers using an open or minimally invasive approach (robotic/laparoscopic/hybrid), regardless of diagnosis, ASA score
ISSN:2296-875X
2296-875X
DOI:10.3389/fsurg.2023.1223225